1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Lorazepam |
| brand | String | Ativan (oral, injectable), Loreev XR |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Benzodiazepines|Benzodiazepine]] • [[:Category:Anxiolytics|Anxiolytic]] • [[:Category:Schedule IV controlled substances|Schedule IV controlled substance]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-0000001D-QINU`"', '"`UNIQ--vote-0000001E-QINU`"', '"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"', '"`UNIQ--vote-00000022-QINU`"' |
| starting_dose | String | Anxiety: 0.5-1 mg PO BID-TID. Insomnia: 1-2 mg PO at bedtime. Status epilepticus: 4 mg IV (adult), repeat after 5-10 minutes if needed. Acute agitation: 1-2 mg IM |
| preparations | String | Tablets 0.5, 1, 2 mg; oral concentrate 2 mg/mL; injection 2 mg/mL and 4 mg/mL; Loreev XR capsules 1, 2, 3 mg |
| fda_max | String | 10 mg/day (anxiety, oral) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • intramuscular • intravenous |
| onset | String | 30-60 minutes (oral); 5 minutes (IV); 15-30 minutes (IM) |
| duration | String | 6-8 hours |
| halflife | String | 12-15 hours (intermediate); '''no active metabolites''' (key clinical feature)'"`UNIQ--ref-00000023-QINU`"' |
| bioavailability | String | ~90% (oral)'"`UNIQ--ref-00000024-QINU`"' |
| pregnancy | String | Some signal for cleft lip/palate with first-trimester exposure (debated); neonatal sedation and withdrawal with third-trimester exposure.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> |
| legal | String | [[USLegal:Schedule IV|Schedule IV controlled substance]] in US. Carries the benzodiazepine class '''Boxed Warning''' for risk of fatal respiratory depression, coma, and death when combined with opioids'"`UNIQ--ref-00000025-QINU`"' |
